Results 41 to 50 of about 23,514 (173)

Screening for latent tuberculosis infection in patients with inflammatory bowel disease: Can interferon-gamma release assays replace the tuberculin skin test?

open access: yesThe Turkish Journal of Gastroenterology, 2018
Background/Aims: Screening for latent tuberculosis infection is mandatory before starting anti-tumor necrosis factor therapy. New assays based on interferon-γ (IFN-γ) release have recently become available and may be more accurate.
José Luis Cabriada   +7 more
doaj   +1 more source

Diagnostic Performance of Comprehensive Point‐of‐Care Ultrasound for Pediatric Tuberculosis in Spain: A Prospective Observational Study

open access: yesJournal of Clinical Ultrasound, Volume 54, Issue 6, Page 1425-1432, July/August 2026.
In children with presumptive tuberculosis, comprehensive point‐of‐care (cPOCUS) identified key thoracic abnormalities with high specificity and excellent inter‐reader reliability. Although diagnostic sensitivity was modest and examinations often incomplete, cPOCUS shows promise as a complementary, radiation‐free imaging tool.
Isabelle Munyangaju   +17 more
wiley   +1 more source

Interferon-gamma release assay performance in northeastern Brazil: influence of the IFNG + 874 A>T polymorphism

open access: yesBrazilian Journal of Infectious Diseases, 2018
Introduction: Latent tuberculosis infection diagnosis based on the release of interferon-gamma in cultures of peripheral blood cells stimulated with Mycobacterium tuberculosis antigens has replaced the tuberculin skin test in many countries with low ...
Valdirene Leão Carneiro   +9 more
doaj   +3 more sources

What Is the Significance of an Accelerated BCG Reaction in Children Living in Low Tuberculosis Incidence Countries?

open access: yesJournal of Paediatrics and Child Health, Volume 62, Issue 7, Page 1186-1191, July 2026.
ABSTRACT Aim In high tuberculosis (TB) incidence countries, accelerated Bacille Calmette–Guérin (BCG) reactions are considered markers of prior Mycobacterium tuberculosis exposure and may prompt investigation. Their significance in low‐incidence countries is unclear.
Widad Al Salmi   +6 more
wiley   +1 more source

Bovine tuberculosis history as a risk factor for recurrence in English cattle herds experiencing a breakdown

open access: yesVeterinary Record, Volume 198, Issue 12, Page e533-e542, 13–27 June 2026.
Abstract Background Bovine tuberculosis (TB) threatens cattle farming in England. Supplementing tuberculin skin testing with the interferon‐gamma blood test during TB incident (breakdown) management can enhance diagnostic sensitivity. We aimed to identify herds at greater risk of recurrence depending on their recent TB history to inform targeted ...
Daisy Duncan   +5 more
wiley   +1 more source

Current Progress in Differentiating Crohn's Disease From Intestinal Tuberculosis

open access: yesiLABMED, Volume 4, Issue 2, Page 78-90, June 2026.
Currently, there are various methods from different fields used to differentiate Crohn's disease from intestinal tuberculosis (ITB). Endoscopic findings are an important cornerstone. They can be used individually or in combination (models) to demonstrate excellent discriminative ability.
Chuyao Zhang, Xiaoyin Zhang
wiley   +1 more source

Inconsistent standard of care for tuberculosis screening and preventive therapy before initiating systemic psoriasis treatment

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 6, Page 737-744, June 2026.
Summary Background and Objectives Preventive tuberculosis (TB) therapy before initiating MTX or IL‐17/IL‐23/IL‐12/23p40 inhibitors for latent tuberculosis infection (LTBI) is supported by indirect evidence of TB reactivations with TNF inhibitors. However, direct evidence for MTX or IL‐17/IL‐23/IL‐12/23p40 inhibitors is limited.
Christoph Zeyen   +4 more
wiley   +1 more source

French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 6, Page 963-979, June 2026.
New 2025 French guidelines update psoriasis management with revised algorithms integrating recent systemic therapies. They recommend methotrexate, adalimumab or ustekinumab as first‐line treatments and provide guidance for special psoriasis forms, comorbidities, pregnancy and long‐term management.
Marie Masson Regnault   +51 more
wiley   +1 more source

Granuloma annulare: relationship to diabetes mellitus, thyroid disorders and tuberculin skin test

open access: yesClinical, Cosmetic and Investigational Dermatology, 2017
Pedram Alirezaei, Mahmood Farshchian Department of Dermatology, Psoriasis Research Center, Farshchian Hospital, Hamadan University of Medical Sciences, Hamadan, Iran Background: Granuloma annulare is a benign inflammatory disease of the skin.
Alirezaei P, Farshchian M
doaj  

Cellular immune response of Curraleiro Pé-duro and Nellore calves following Mycobacterium bovis-BCG vaccination

open access: yesPesquisa Veterinária Brasileira, 2013
The present study aimed to assess the CD4, CD8 and γδ blood levels for Curraleiro Pé-duro, as well as the specific IFN-γ response after BCG vaccination using flow cytometry.
Mayara Fernanda Maggioli   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy